Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fuchs

Showing results (611-620 of 672) with videos related to

Pageof 68
Sort By:
Investigational New Drugs|February 23, 2011
Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in miceGrace-Ifeyinwa Onimoe, Aiguo Liu, Li Lin, et al.
The Journal of Biological Chemistry|March 23, 2012
Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitorsJacques J Kessl, Nivedita Jena, Yasuhiro Koh, et al.
Phytochemistry|January 19, 2015
Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensisYulin Ren, Chunhua Yuan, Youcai Deng, et al.
Journal of Natural Products|January 11, 2013
Bioactive flavaglines and other constituents isolated from Aglaia perviridisLi Pan, Ulyana Muñoz Acuña, Jie Li, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 7, 2026
CURE ID: A Platform to Collect Real-World Treatment Data for Drug Repurposing in Rare Genetic DisordersTahsin Farid, Maura R Z Ruzhnikov, Mili Duggal, et al.
Acta Crystallographica. Section F, Structural Biology Communications|July 5, 2022
Serial crystallography with multi-stage merging of thousands of imagesAlexei S Soares, Yusuke Yamada, Jean Jakoncic, et al.
Nucleic Acids Research|October 9, 2012
HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitorHao Wang, Kellie A Jurado, Xiaolin Wu, et al.
European Journal of Medicinal Chemistry|April 18, 2023
Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradationRobert J Tokarski, Chia M Sharpe, Andrew C Huntsman, et al.
Tissue Engineering. Part C, Methods|September 26, 2019
Rabbit Model of Physeal Injury for the Evaluation of Regenerative Medicine ApproachesYangyi Yu, Francisco Rodriguez-Fontan, Kevin Eckstein, et al.
Surgery Open Science|July 26, 2021
Epidemiology of pediatric trauma during the COVID-19 pandemic shelter in placeKovi E Bessoff, Ryan W Han, Min Cho, et al.
Pageof 68

Showing results (611-620 of 672) with videos related to

Sort By:
Pageof 68
Investigational New Drugs|February 23, 2011
Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in miceGrace-Ifeyinwa Onimoe, Aiguo Liu, Li Lin, et al.
The Journal of Biological Chemistry|March 23, 2012
Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitorsJacques J Kessl, Nivedita Jena, Yasuhiro Koh, et al.
Phytochemistry|January 19, 2015
Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensisYulin Ren, Chunhua Yuan, Youcai Deng, et al.
Journal of Natural Products|January 11, 2013
Bioactive flavaglines and other constituents isolated from Aglaia perviridisLi Pan, Ulyana Muñoz Acuña, Jie Li, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 7, 2026
CURE ID: A Platform to Collect Real-World Treatment Data for Drug Repurposing in Rare Genetic DisordersTahsin Farid, Maura R Z Ruzhnikov, Mili Duggal, et al.
Acta Crystallographica. Section F, Structural Biology Communications|July 5, 2022
Serial crystallography with multi-stage merging of thousands of imagesAlexei S Soares, Yusuke Yamada, Jean Jakoncic, et al.
Nucleic Acids Research|October 9, 2012
HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitorHao Wang, Kellie A Jurado, Xiaolin Wu, et al.
European Journal of Medicinal Chemistry|April 18, 2023
Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradationRobert J Tokarski, Chia M Sharpe, Andrew C Huntsman, et al.
Tissue Engineering. Part C, Methods|September 26, 2019
Rabbit Model of Physeal Injury for the Evaluation of Regenerative Medicine ApproachesYangyi Yu, Francisco Rodriguez-Fontan, Kevin Eckstein, et al.
Surgery Open Science|July 26, 2021
Epidemiology of pediatric trauma during the COVID-19 pandemic shelter in placeKovi E Bessoff, Ryan W Han, Min Cho, et al.
Pageof 68